<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33807542</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>RNA-Binding Proteins and the Complex Pathophysiology of ALS.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2598</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22052598</ELocationID><Abstract><AbstractText>Genetic analyses of patients with amyotrophic lateral sclerosis (ALS) have identified disease-causing mutations and accelerated the unveiling of complex molecular pathogenic mechanisms, which may be important for understanding the disease and developing therapeutic strategies. Many disease-related genes encode RNA-binding proteins, and most of the disease-causing RNA or proteins encoded by these genes form aggregates and disrupt cellular function related to RNA metabolism. Disease-related RNA or proteins interact or sequester other RNA-binding proteins. Eventually, many disease-causing mutations lead to the dysregulation of nucleocytoplasmic shuttling, the dysfunction of stress granules, and the altered dynamic function of the nucleolus as well as other membrane-less organelles. As RNA-binding proteins are usually components of several RNA-binding protein complexes that have other roles, the dysregulation of RNA-binding proteins tends to cause diverse forms of cellular dysfunction. Therefore, understanding the role of RNA-binding proteins will help elucidate the complex pathophysiology of ALS. Here, we summarize the current knowledge regarding the function of disease-associated RNA-binding proteins and their role in the dysfunction of membrane-less organelles.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Wanil</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Cosmetic Science and Technology, Daegu Haany University, Hanuidae-ro 1, Gyeongsan, Gyeongbuk 38610, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Do-Yeon</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0003-2200-7396</Identifier><AffiliationInfo><Affiliation>Department of Pharmacology, School of Dentistry, Kyungpook National University, Daegu 41940, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Kyung-Ha</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Division of Cosmetic Science and Technology, Daegu Haany University, Hanuidae-ro 1, Gyeongsan, Gyeongbuk 38610, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2017R1D1A1B03033241</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant><Grant><GrantID>2018R1A5A2025272</GrantID><Agency>National Research Foundation of Korea</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RNA-binding protein</Keyword><Keyword MajorTopicYN="N">membrane-less organelles</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33807542</ArticleId><ArticleId IdType="pmc">PMC7961459</ArticleId><ArticleId IdType="doi">10.3390/ijms22052598</ArticleId><ArticleId IdType="pii">ijms22052598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rowland L.P. How Amyotrophic Lateral Sclerosis Got Its Name. Arch. Neurol. 2001;58:512&#x2013;515. doi: 10.1001/archneur.58.3.512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.58.3.512</ArticleId><ArticleId IdType="pubmed">11255459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Berg L.H.V.D. Amyotrophic Lateral Sclerosis. Nat. Rev. Dis. Prim. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W. The Phenotypic Variability of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2014;10:661&#x2013;670. doi: 10.1038/nrneurol.2014.184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2014.184</ArticleId><ArticleId IdType="pubmed">25311585</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Orrell R.W. Pathogenesis of Amyotrophic Lateral Sclerosis. Br. Med. Bull. 2016;119:87&#x2013;98. doi: 10.1093/bmb/ldw026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldw026</ArticleId><ArticleId IdType="pubmed">27450455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrites D., Vaz A.R. Microglia Centered Pathogenesis in Als: Insights in Cell Interconnectivity. Front. Cell. Neurosci. 2014;8:117. doi: 10.3389/fncel.2014.00117.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00117</ArticleId><ArticleId IdType="pmc">PMC4033073</ArticleId><ArticleId IdType="pubmed">24904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Valori C.F., Brambilla L., Martorana F., Rossi D. The Multifaceted Role of Glial Cells in Amyotrophic Lateral Sclerosis. Cell. Mol. Life Sci. 2013;71:287&#x2013;297. doi: 10.1007/s00018-013-1429-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1429-7</ArticleId><ArticleId IdType="pubmed">23912896</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P.C., Hentati A., Donaldson D.H., Goto J., O&#x2019;Regan J.P., Deng H.-X., et al. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo G.M., Manfredi G. Exploring New Pathways of Neurodegeneration in ALS: The Role of Mitochondria Quality Control. Brain Res. 2015;1607:36&#x2013;46. doi: 10.1016/j.brainres.2014.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.065</ArticleId><ArticleId IdType="pmc">PMC4385426</ArticleId><ArticleId IdType="pubmed">25301687</ArticleId></ArticleIdList></Reference><Reference><Citation>Tafuri F., Ronchi D., Magri F., Comi G.P., Corti S. SOD1 Misplacing and Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis Pathogenesis. Front. Cell. Neurosci. 2015;9:336. doi: 10.3389/fncel.2015.00336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00336</ArticleId><ArticleId IdType="pmc">PMC4548205</ArticleId><ArticleId IdType="pubmed">26379505</ArticleId></ArticleIdList></Reference><Reference><Citation>Tadic V., Prell T., Lautenschlaeger J., Grosskreutz J. The ER Mitochondria Calcium Cycle and ER Stress Response as Therapeutic Targets in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2014;8:147. doi: 10.3389/fncel.2014.00147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00147</ArticleId><ArticleId IdType="pmc">PMC4039088</ArticleId><ArticleId IdType="pubmed">24910594</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic Lateral Sclerosis&#x2014;a Model of Corticofugal Axonal Spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini T., Fiore M., Tesauro M., Malagoli C., Consonni M., Violi F., Arcolin E., Iacuzio L., Conti G.O., Cristaldi A., et al. Clinical and Lifestyle Factors and Risk of Amyotrophic Lateral Sclerosis: A Population-Based Case-Control Study. Int. J. Environ. Res. Public Health. 2020;17:857. doi: 10.3390/ijerph17030857.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17030857</ArticleId><ArticleId IdType="pmc">PMC7037077</ArticleId><ArticleId IdType="pubmed">32019087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson E.V., McDermott E.V.H.C.J. Supportive and Symptomatic Management of Amyotrophic Lateral Sclerosis. Nat. Rev. Neurol. 2016;12:526&#x2013;538. doi: 10.1038/nrneurol.2016.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.111</ArticleId><ArticleId IdType="pubmed">27514291</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R., Pisano A., Sabalic A., Farace C., Fenu G., Lintas S., Forte G., Bocca B., Madeddu R. An Overview on Amyotrophic Lateral Sclerosis and Cadmium. Neurol. Sci. 2021;42:531&#x2013;537. doi: 10.1007/s10072-020-04957-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04957-7</ArticleId><ArticleId IdType="pmc">PMC7843544</ArticleId><ArticleId IdType="pubmed">33280067</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton E.A., Chi&#xf2; A., Traynor B.J. State of Play in Amyotrophic Lateral Sclerosis Genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Hatano M., Suzuki N. RNA Binding Proteins and the Pathological Cascade in ALS/FTD Neurodegeneration. Sci. Transl. Med. 2017;9:eaah5436. doi: 10.1126/scitranslmed.aah5436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aah5436</ArticleId><ArticleId IdType="pubmed">29118263</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Jr., Cleveland D.W. Decoding ALS: From Genes to Mechanism. Nat. Cell Biol. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y.C., Ng C.S., Xiang P., Liu H., Zhang K., Mohamud Y., Luo H. Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2020;13:78. doi: 10.3389/fnmol.2020.00078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.00078</ArticleId><ArticleId IdType="pmc">PMC7273501</ArticleId><ArticleId IdType="pubmed">32547363</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudman J., Qi X. Stress Granule Dysregulation in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci. 2020;14:598517. doi: 10.3389/fncel.2020.598517.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.598517</ArticleId><ArticleId IdType="pmc">PMC7705167</ArticleId><ArticleId IdType="pubmed">33281563</ArticleId></ArticleIdList></Reference><Reference><Citation>Dervishi I., Gozutok O., Murnan K., Gautam M., Heller D., Bigio E., Ozdinler P.H. Protein-Protein Interactions Reveal Key Canonical Pathways, Upstream Regulators, Interactome Domains, and Novel Targets in ALS. Sci. Rep. 2018;8:1&#x2013;19. doi: 10.1038/s41598-018-32902-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-32902-4</ArticleId><ArticleId IdType="pmc">PMC6170493</ArticleId><ArticleId IdType="pubmed">30283000</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez J., Corbera-Bellalta M., Nogales G., Raguer N., Garc&#xed;a-Arum&#xed; E., Badia-Canto M., Llad&#xf3;-Carb&#xf3; E., &#xc1;lvarez-Sab&#xed;n J. Mutational Analysis of the Cu/Zn Superoxide Dismutase Gene in a Catalan ALS Population: Should All Sporadic ALS Cases Also Be Screened for SOD1? J. Neurol. Sci. 2006;247:21&#x2013;28. doi: 10.1016/j.jns.2006.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2006.03.006</ArticleId><ArticleId IdType="pubmed">16674979</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Hewitt C., Highley J.R., Brockington A., Milano A., Man S., Martindale J., Hartley J., Walsh T., Gelsthorpe C., et al. Clinico-Pathological Features in Amyotrophic Lateral Sclerosis with Expansions in C9ORF72. Brain. 2012;135:751&#x2013;764. doi: 10.1093/brain/awr365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr365</ArticleId><ArticleId IdType="pmc">PMC3286332</ArticleId><ArticleId IdType="pubmed">22366792</ArticleId></ArticleIdList></Reference><Reference><Citation>Baradaran-Heravi Y., Van Broeckhoven C., van der Zee J. Stress Granule Mediated Protein Aggregation and Underlying Gene Defects in the FTD-ALS Spectrum. Neurobiol. Dis. 2020;134:104639. doi: 10.1016/j.nbd.2019.104639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104639</ArticleId><ArticleId IdType="pubmed">31626953</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Erion R., King O.D., Diaz Z., Nakaya T., Ibrahim F., Kim H.-J., Mojsilovic-Petrovic J., Panossian S., et al. Evaluating the Role of the FUS/TLS-Related Gene EWSR1 in Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2012;21:2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden A.C., Kim H.-J., Hart M.P., Chen-Plotkin A.S., Johnson B.S., Fang X., Armakola M., Geser F., Greene R., Lu M.M., et al. Ataxin-2 Intermediate-Length Polyglutamine Expansions Are Associated with Increased Risk for ALS. Nat. Cell Biol. 2010;466:1069&#x2013;1075. doi: 10.1038/nature09320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09320</ArticleId><ArticleId IdType="pmc">PMC2965417</ArticleId><ArticleId IdType="pubmed">20740007</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.-D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in Prion-Like Domains in hnRNPA2B1 and hnRNPA1 Cause Multisystem Proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwiatkowski T.J., Jr., Bosco D.A., Leclerc A.L., Tamrazian E., Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J., Munsat T., et al. Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis. Science. 2009;323:1205&#x2013;1208. doi: 10.1126/science.1166066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166066</ArticleId><ArticleId IdType="pubmed">19251627</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Bentmann E., Dormann D., Jawaid A., DeJesus-Hernandez M., Ansorge O., Roeber S., Kretzschmar H.A., Munoz D.G., Kusaka H., et al. FET Proteins TAF15 and EWS are Selective Markers that Distinguish FTLD with FUS Pathology from Amyotrophic Lateral Sclerosis with FUS Mutations. Brain. 2011;134:2595&#x2013;2609. doi: 10.1093/brain/awr201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr201</ArticleId><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T., Van Der Zee J., Sleegers K., Engelborghs S., Vandenberghe R., Gijselinck I., Broeck M.V.D., Mattheijssens M., Peeters K., De Deyn P.P., et al. Genetic Contribution of FUS to Frontotemporal Lobar Degeneration. Neurology. 2010;74:366&#x2013;371. doi: 10.1212/WNL.0b013e3181ccc732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ccc732</ArticleId><ArticleId IdType="pubmed">20124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigaki S., Sobue G. Importance of Functional Loss of FUS in FTLD/ALS. Front. Mol. Biosci. 2018;5:44. doi: 10.3389/fmolb.2018.00044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2018.00044</ArticleId><ArticleId IdType="pmc">PMC5943504</ArticleId><ArticleId IdType="pubmed">29774215</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasad A., Bharathi V., Sivalingam V., Girdhar A., Patel B.K. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci. 2019;12:25. doi: 10.3389/fnmol.2019.00025.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00025</ArticleId><ArticleId IdType="pmc">PMC6382748</ArticleId><ArticleId IdType="pubmed">30837838</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Zhu Q., Gendron T.F., Saberi S., McAlonis-Downes M., Seelman A., Stauffer J.E., Jafar-Nejad P., Drenner K., Schulte D., et al. Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs. Neuron. 2016;90:535&#x2013;550. doi: 10.1016/j.neuron.2016.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.006</ArticleId><ArticleId IdType="pmc">PMC4860075</ArticleId><ArticleId IdType="pubmed">27112497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D., O&#x2019;Rourke J.G., Meera P., Muhammad A.K.M.G., Grant S., Simpkinson M., Bell S., Carmona S., Ornelas L., Sahabian A., et al. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion. Sci. Transl. Med. 2013;5:208ra149. doi: 10.1126/scitranslmed.3007529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Higginbottom A., Stopford M.J., Highley J.R., Ince P.G., Wharton S.B., Pickering-Brown S., Kirby J., Hautbergue G.M., Shaw P.J. Antisense RNA Foci in the Motor Neurons of C9ORF72-ALS Patients are Associated with TDP-43 proteinopathy. Acta Neuropathol. 2015;130:63&#x2013;75. doi: 10.1007/s00401-015-1429-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1429-9</ArticleId><ArticleId IdType="pmc">PMC4468790</ArticleId><ArticleId IdType="pubmed">25943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Liu Y., Ba&#xf1;ez-Coronel M., Reid T., Pletnikova O., Lewis J., Miller T.M., Harms M.B., Falchook A.E., Subramony S.H., et al. RAN Proteins and RNA Foci from Antisense Transcripts in C9ORF72 ALS and Frontotemporal Dementia. Proc. Natl. Acad. Sci. USA. 2013;110:E4968&#x2013;E4977. doi: 10.1073/pnas.1315438110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1315438110</ArticleId><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Martier R., Liefhebber J.M., Garc&#xed;a-Osta A., Miniarikova J., Cuadrado-Tejedor M., Espelosin M., Ursua S., Petry H., van Deventer S.J., Evers M.M., et al. Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy. Mol. Ther. Nucleic Acids. 2019;16:26&#x2013;37. doi: 10.1016/j.omtn.2019.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.02.001</ArticleId><ArticleId IdType="pmc">PMC6393708</ArticleId><ArticleId IdType="pubmed">30825670</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.-H., Hung S.-T., Hendricks E., Linares G.R., Wang Y., Son E.Y., et al. Haploinsufficiency Leads to Neurodegeneration in C9ORF72 ALS/FTD Human Induced Motor Neurons. Nat. Med. 2018;24:313&#x2013;325. doi: 10.1038/nm.4490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>McEachin Z.T., Parameswaran J., Raj N., Bassell G.J., Jiang J. RNA-Mediated Toxicity in C9orf72 ALS and FTD. Neurobiol. Dis. 2020;145:105055. doi: 10.1016/j.nbd.2020.105055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105055</ArticleId><ArticleId IdType="pmc">PMC7572710</ArticleId><ArticleId IdType="pubmed">32829028</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Bieniek K.F., Gendron T.F., Caulfield T., Lin W.-L., DeJesus-Hernandez M., van Blitterswijk M.M., Jansen-West K., Paul J.W., Rademakers R., et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS. Neuron. 2013;77:639&#x2013;646. doi: 10.1016/j.neuron.2013.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.02.004</ArticleId><ArticleId IdType="pmc">PMC3593233</ArticleId><ArticleId IdType="pubmed">23415312</ArticleId></ArticleIdList></Reference><Reference><Citation>Gendron T.F., Bieniek K.F., Zhang Y.-J., Jansen-West K., Ash P.E.A., Caulfield T., Daughrity L., Dunmore J.H., Castanedes-Casey M., Chew J., et al. Antisense Transcripts of the Expanded C9ORF72 Hexanucleotide Repeat form Nuclear RNA Foci and Undergo Repeat-Associated Non-ATG Translation in c9FTD/ALS. Acta Neuropathol. 2013;126:829&#x2013;844. doi: 10.1007/s00401-013-1192-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1192-8</ArticleId><ArticleId IdType="pmc">PMC3830741</ArticleId><ArticleId IdType="pubmed">24129584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori K., Arzberger T., Gr&#xe4;sser F.A., Gijselinck I., May S., Rentzsch K., Weng S.-M., Schludi M.H., Van Der Zee J., Cruts M., et al. Bidirectional Transcripts of the Expanded C9orf72 Hexanucleotide Repeat Are Translated into Aggregating Dipeptide Repeat Proteins. Acta Neuropathol. 2013;126:881&#x2013;893. doi: 10.1007/s00401-013-1189-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1189-3</ArticleId><ArticleId IdType="pubmed">24132570</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Zhang Z., Morgens D.W., Hayes L.R., Lee S., Portz B., Xie Y., Nguyen B.V., Haney M.S., et al. CRISPR-Cas9 Screens Identify the RNA Helicase DDX3X as a Repressor of C9ORF72 (GGGGCC)n Repeat-Associated Non-AUG Translation. Neuron. 2019;104:885&#x2013;898.e8. doi: 10.1016/j.neuron.2019.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-H., Zhang P., Kim H.J., Mitrea D.M., Sarkar M., Freibaum B.D., Cika J., Coughlin M., Messing J., Molliex A., et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell. 2016;167:774&#x2013;788.e17. doi: 10.1016/j.cell.2016.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.002</ArticleId><ArticleId IdType="pmc">PMC5079111</ArticleId><ArticleId IdType="pubmed">27768896</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Mori E., Kato M., Xiang S., Wu L., Kwon I., McKnight S.L. Toxic PR Poly-Dipeptides Encoded by the C9orf72 Repeat Expansion Target LC Domain Polymers. Cell. 2016;167:789&#x2013;802.e12. doi: 10.1016/j.cell.2016.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.10.003</ArticleId><ArticleId IdType="pmc">PMC5076566</ArticleId><ArticleId IdType="pubmed">27768897</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Taylor J.P. The Role of Dipeptide Repeats in C9ORF72-Related ALS-FTD. Front. Mol. Neurosci. 2017;10:35. doi: 10.3389/fnmol.2017.00035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00035</ArticleId><ArticleId IdType="pmc">PMC5303742</ArticleId><ArticleId IdType="pubmed">28243191</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbaum-Garfinkle S. Matter over Mind: Liquid Phase Separation and Neurodegeneration. J. Biol. Chem. 2019;294:7160&#x2013;7168. doi: 10.1074/jbc.REV118.001188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.REV118.001188</ArticleId><ArticleId IdType="pmc">PMC6509495</ArticleId><ArticleId IdType="pubmed">30914480</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambadipudi S., Biernat J., Riedel D., Mandelkow E., Zweckstetter M. Liquid&#x2013;Liquid Phase Separation of the Microtubule-Binding Repeats of the Alzheimer-Related Protein Tau. Nat. Commun. 2017;8:1&#x2013;13. doi: 10.1038/s41467-017-00480-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00480-0</ArticleId><ArticleId IdType="pmc">PMC5561136</ArticleId><ArticleId IdType="pubmed">28819146</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S., Eftekharzadeh B., Tepper K., Zoltowska K.M., Bennett R.E., Dujardin S., Laskowski P.R., MacKenzie D., Kamath T., Commins C., et al. Tau Protein Liquid&#x2013;Liquid Phase Separation Can Initiate Tau Aggregation. EMBO J. 2018;37:e98049. doi: 10.15252/embj.201798049.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798049</ArticleId><ArticleId IdType="pmc">PMC5881631</ArticleId><ArticleId IdType="pubmed">29472250</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S., Dormann D. Liquid&#x2013;Liquid Phase Separation in Disease. Annu. Rev. Genet. 2019;53:171&#x2013;194. doi: 10.1146/annurev-genet-112618-043527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genet-112618-043527</ArticleId><ArticleId IdType="pubmed">31430179</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallini C., Khalil B., Smith C.L., Rossoll W. Traffic Jam at the Nuclear Pore: All Roads Lead to Nucleocytoplasmic Transport Defects in ALS/FTD. Neurobiol. Dis. 2020;140:104835. doi: 10.1016/j.nbd.2020.104835.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104835</ArticleId><ArticleId IdType="pmc">PMC7253339</ArticleId><ArticleId IdType="pubmed">32179176</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Mediani L., Alberti S., Carra S. ALS and FTD: Where RNA Metabolism Meets Protein Quality Control. Semin. Cell Dev. Biol. 2020;99:183&#x2013;192. doi: 10.1016/j.semcdb.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.06.003</ArticleId><ArticleId IdType="pubmed">31254610</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum B.D., Lu Y., Lopez-Gonzalez R., Kim N.C., Almeida S., Lee K.-H., Badders N., Valentine M., Miller B.L., Wong P.C., et al. GGGGCC Repeat Expansion in C9orf72 Compromises Nucleocytoplasmic Transport. Nat. Cell Biol. 2015;525:129&#x2013;133. doi: 10.1038/nature14974.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14974</ArticleId><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Taylor J.P. Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases. Neuron. 2017;96:285&#x2013;297. doi: 10.1016/j.neuron.2017.07.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.029</ArticleId><ArticleId IdType="pmc">PMC5678982</ArticleId><ArticleId IdType="pubmed">29024655</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Polymenidou M., Cleveland D.W. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>McGurk L., Mojsilovic-Petrovic J., Van Deerlin V.M., Shorter J., Kalb R.G., Lee V.M., Trojanowski J.Q., Lee E.B., Bonini N.M. Nuclear Poly(ADP-Ribose) Activity Is a Therapeutic Target in Amyotrophic Lateral Sclerosis. Acta Neuropathol. Commun. 2018;6:1&#x2013;15. doi: 10.1186/s40478-018-0586-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0586-1</ArticleId><ArticleId IdType="pmc">PMC6114235</ArticleId><ArticleId IdType="pubmed">30157956</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou C.-C., Zhang Y., Umoh M.E., Vaughan S.W., Lorenzini I., Liu F., Sayegh M., Donlin-Asp P.G., Chen Y.H., Duong D.M., et al. TDP-43 Pathology Disrupts Nuclear Pore Complexes and Nucleocytoplasmic Transport in ALS/FTD. Nat. Neurosci. 2018;21:228&#x2013;239. doi: 10.1038/s41593-017-0047-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-017-0047-3</ArticleId><ArticleId IdType="pmc">PMC5800968</ArticleId><ArticleId IdType="pubmed">29311743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Daigle J.G., Cunningham K.M., Coyne A.N., Ruan K., Grima J.C., Bowen K.E., Wadhwa H., Yang P., Rigo F., et al. Stress Granule Assembly Disrupts Nucleocytoplasmic Transport. Cell. 2018;173:958&#x2013;971.e17. doi: 10.1016/j.cell.2018.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC6083872</ArticleId><ArticleId IdType="pubmed">29628143</ArticleId></ArticleIdList></Reference><Reference><Citation>Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M.E., Mackenzie I.R., Capell A., Schmid B., et al. ALS-Associated Fused in Sarcoma (FUS) Mutations Disrupt Transportin-Mediated Nuclear Import. EMBO J. 2010;29:2841&#x2013;2857. doi: 10.1038/emboj.2010.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.143</ArticleId><ArticleId IdType="pmc">PMC2924641</ArticleId><ArticleId IdType="pubmed">20606625</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Zhang J., Kwinter D.M., Zhai J., Jia H., Jia J., Zhu H. Nuclear Localization Sequence of FUS and Induction of Stress Granules by ALS Mutants. Neurobiol. Aging. 2011;32:2323.e27&#x2013;2323.e40. doi: 10.1016/j.neurobiolaging.2010.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.06.010</ArticleId><ArticleId IdType="pmc">PMC2997923</ArticleId><ArticleId IdType="pubmed">20674093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack E.G., Luisier R., Taha D.M., Neeves J., Modic M., Mitchell J.S., Meyer I., Greensmith L., Newcombe J., Ule J., et al. Widespread FUS Mislocalization Is a Molecular Hallmark of Amyotrophic Lateral Sclerosis. Brain. 2019;142:2572&#x2013;2580. doi: 10.1093/brain/awz217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz217</ArticleId><ArticleId IdType="pmc">PMC6735815</ArticleId><ArticleId IdType="pubmed">31368485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Seki M., Tsunoda Y., Uchiyama H., Suzuki N. Nuclear Transport Impairment of Amyotrophic Lateral Sclerosis-Linked Mutations in FUS/TLS. Ann. Neurol. 2010;69:152&#x2013;162. doi: 10.1002/ana.22246.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22246</ArticleId><ArticleId IdType="pubmed">21280085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V., Carr&#xec; M.T., Cozzolino M., Achsel T. Mislocalised FUS Mutants Stall Spliceosomal snRNPs in the Cytoplasm. Neurobiol. Dis. 2013;55:120&#x2013;128. doi: 10.1016/j.nbd.2013.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.03.003</ArticleId><ArticleId IdType="pubmed">23523636</ArticleId></ArticleIdList></Reference><Reference><Citation>Reber S., Stettler J., Filosa G., Colombo M., Jutzi D., Lenzken S.C., Schweingruber C., Bruggmann R., Bachi A., Barabino S.M., et al. Minor Intron Splicing is Regulated by FUS and Affected by ALS-Associated FUS Mutants. EMBO J. 2016;35:1504&#x2013;1521. doi: 10.15252/embj.201593791.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201593791</ArticleId><ArticleId IdType="pmc">PMC4946139</ArticleId><ArticleId IdType="pubmed">27252488</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi S., Rompietti V., Antonucci Y., Giovannini D., Scopa C., Scaricamazza S., Scardigli R., Cestra G., Serafino A., Carr&#xec; M.T., et al. UsnRNP Trafficking Is Regulated by Stress Granules and Compromised by Mutant ALS Proteins. Neurobiol. Dis. 2020;138:104792. doi: 10.1016/j.nbd.2020.104792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104792</ArticleId><ArticleId IdType="pubmed">32027933</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Michiels E., Gijselinck I., Sieben A., Jovi&#x10d;i&#x107; A., De Baets G., Scheveneels W., Steyaert J., Cuijt I., et al. Drosophila Screen Connects Nuclear Transport Genes to DPR Pathology in c9ALS/FTD. Sci. Rep. 2016;6:20877. doi: 10.1038/srep20877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B., Robberecht W., Bosch L.V.D. RNA Toxicity in Non-Coding Repeat Expansion Disorders. EMBO J. 2020;39:e101112. doi: 10.15252/embj.2018101112.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2018101112</ArticleId><ArticleId IdType="pmc">PMC6939197</ArticleId><ArticleId IdType="pubmed">31721251</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Donnelly C.J., Haeusler A.R., Grima J.C., Machamer J.B., Steinwald P., Daley E.L., Miller S.J., Cunningham K.M., Vidensky S., et al. The C9orf72 Repeat Expansion Disrupts Nucleocytoplasmic Transport. Nat. Cell Biol. 2015;525:56&#x2013;61. doi: 10.1038/nature14973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14973</ArticleId><ArticleId IdType="pmc">PMC4800742</ArticleId><ArticleId IdType="pubmed">26308891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Daley E.L., Gleixner A.M., Mann J.R., Kour S., Mawrie D., Anderson E.N., Kofler J., Donnelly C.J., Kiskinis E., et al. RNA Dependent Suppression of C9orf72 ALS/FTD Associated Neurodegeneration by Matrin-3. Acta Neuropathol. Commun. 2020;8:1&#x2013;20. doi: 10.1186/s40478-020-01060-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01060-y</ArticleId><ArticleId IdType="pmc">PMC7603783</ArticleId><ArticleId IdType="pubmed">33129345</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Lopez-Gonzalez R., Kunz R.C., Gangopadhyay J., Borufka C., Gygi S.P., Gao F.-B., Reed R. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-Splicing in ALS/FTD Patients. Cell Rep. 2017;19:2244&#x2013;2256. doi: 10.1016/j.celrep.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.056</ArticleId><ArticleId IdType="pmc">PMC5653973</ArticleId><ArticleId IdType="pubmed">28614712</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei Y., German Consortium for Frontotemporal Lobar Degeneration. Mori K., Werner G., Arzberger T., Zhou Q., Khosravi B., Japtok J., Hermann A., Sommacal A., et al. Poly-Glycine&#x2013;Alanine Exacerbates C9orf72 Repeat Expansion-Mediated DNA Damage via Sequestration of Phosphorylated ATM and Loss of Nuclear hnRNPA3. Acta Neuropathol. 2020;139:99&#x2013;118. doi: 10.1007/s00401-019-02082-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02082-0</ArticleId><ArticleId IdType="pmc">PMC6942035</ArticleId><ArticleId IdType="pubmed">31642962</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson Y.S., Flood L., Robinson A.C., Nihei Y., Mori K., Rollinson S., Richardson A., Benson B.C., Jones M., Snowden J.S., et al. Heterogeneous Ribonuclear Protein a3 (hnRNP A3) Is Present in Dipeptide Repeat Protein Containing Inclusions in Frontotem-Poral Lobar Degeneration and Motor Neurone Disease Associated with Expansions in C9orf72 Gene. Acta Neuropathol. Commun. 2017;5:31. doi: 10.1186/s40478-017-0437-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0437-5</ArticleId><ArticleId IdType="pmc">PMC5399321</ArticleId><ArticleId IdType="pubmed">28431575</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Shu S., Wang R.R., Liu F., Cui B., Guo X.N., Lu C.X., Li X.G., Liu M.S., Peng B., et al. Whole-Exome Sequencing Identifies a Missense Mutation in hnRNPA1 in a Family with Flail Arm ALS. Neurology. 2016;87:1763&#x2013;1769. doi: 10.1212/WNL.0000000000003256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003256</ArticleId><ArticleId IdType="pubmed">27694260</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-H., Fallini C., Ticozzi N., Keagle P.J., Sapp P.C., Piotrowska K., Lowe P., Koppers M., McKenna-Yasek D., Baron D.M., et al. Mutations in the Profilin 1 Gene Cause Familial Amyotrophic Lateral Sclerosis. Nat. Cell Biol. 2012;488:499&#x2013;503. doi: 10.1038/nature11280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11280</ArticleId><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Vance C., Scotter E.L., Troakes C., Wong C.H., Topp S., Maekawa S., King A., Mitchell J.C., Lund K., et al. Novel Mutations Support a Role for Profilin 1 in the Pathogenesis of ALS. Neurobiol. Aging. 2015;36:1602.e17&#x2013;1602.e27. doi: 10.1016/j.neurobiolaging.2014.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.10.032</ArticleId><ArticleId IdType="pmc">PMC4357530</ArticleId><ArticleId IdType="pubmed">25499087</ArticleId></ArticleIdList></Reference><Reference><Citation>Giampetruzzi A., Danielson E.W., Gumina V., Jeon M., Boopathy S., Brown R.H., Ratti A., Landers J.E., Fallini C. Modulation of Actin Polymerization Affects Nucleocytoplasmic Transport in Multiple Forms of Amyotrophic Lateral Sclerosis. Nat. Commun. 2019;10:1&#x2013;15. doi: 10.1038/s41467-019-11837-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11837-y</ArticleId><ArticleId IdType="pmc">PMC6707192</ArticleId><ArticleId IdType="pubmed">31444357</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolozin B., Ivanov P. Stress Granules and Neurodegeneration. Nat. Rev. Neurosci. 2019;20:649&#x2013;666. doi: 10.1038/s41583-019-0222-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-019-0222-5</ArticleId><ArticleId IdType="pmc">PMC6986315</ArticleId><ArticleId IdType="pubmed">31582840</ArticleId></ArticleIdList></Reference><Reference><Citation>Samir P., Kesavardhana S., Patmore D.M., Gingras S., Malireddi R.K.S., Karki R., Guy C.S., Briard B., Place D.E., Bhattacharya A., et al. DDX3X Acts as a Live-or-Die Checkpoint in Stressed Cells by Regulating NLRP3 Inflammasome. Nat. Cell Biol. 2019;573:590&#x2013;594. doi: 10.1038/s41586-019-1551-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1551-2</ArticleId><ArticleId IdType="pmc">PMC6980284</ArticleId><ArticleId IdType="pubmed">31511697</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A., Velde C.V. Alterations in Stress Granule Dynamics Driven by TDP-43 and FUS: A Link to Pathological Inclusions in ALS? Front. Cell. Neurosci. 2015;9:423. doi: 10.3389/fncel.2015.00423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00423</ArticleId><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D. Stress Granules as Crucibles of ALS Pathogenesis. J. Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Lin A.Y., Ebata A., Boon J.Y., Reid W., Xu Y.-F., Kobrin K., Murphy G.J., Petrucelli L., Wolozin B. ALS-Linked Mutations Enlarge TDP-43-Enriched Neuronal RNA Granules in the Dendritic Arbor. J. Neurosci. 2014;34:4167&#x2013;4174. doi: 10.1523/JNEUROSCI.2350-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2350-13.2014</ArticleId><ArticleId IdType="pmc">PMC3960463</ArticleId><ArticleId IdType="pubmed">24647938</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilks N., Kedersha N., Ayodele M., Shen L., Stoecklin G., Dember L.M., Anderson P. Stress Granule Assembly Is Mediated by Prion-like Aggregation of TIA-1. Mol. Biol. Cell. 2004;15:5383&#x2013;5398. doi: 10.1091/mbc.e04-08-0715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e04-08-0715</ArticleId><ArticleId IdType="pmc">PMC532018</ArticleId><ArticleId IdType="pubmed">15371533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonhoff U., Ralser M., Welzel F., Piccini I., Balzereit D., Yaspo M.-L., Lehrach H., Krobitsch S. Ataxin-2 Interacts with the DEAD/H-Box RNA Helicase DDX6 and Interferes with P-Bodies and Stress Granules. Mol. Biol. Cell. 2007;18:1385&#x2013;1396. doi: 10.1091/mbc.e06-12-1120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e06-12-1120</ArticleId><ArticleId IdType="pmc">PMC1838996</ArticleId><ArticleId IdType="pubmed">17392519</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Soo K.Y., Warraich S.T., Sundaramoorthy V., Blair I.P., Atkin J.D. Ataxin-2 Interacts with FUS and Intermediate-Length Polyglutamine Expansions Enhance FUS-Related Pathology in Amyotrophic Lateral Sclerosis. Hum. Mol. Genet. 2012;22:717&#x2013;728. doi: 10.1093/hmg/dds479.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds479</ArticleId><ArticleId IdType="pubmed">23172909</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z., Jiao B., Hou L., Xiao T., Liu X., Wang J., Xu J., Zhou L., Yan X., Tang B., et al. Mutation Analysis of the TIA1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Neurobiol. Aging. 2018;64:160.e9&#x2013;160.e12. doi: 10.1016/j.neurobiolaging.2017.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.12.017</ArticleId><ArticleId IdType="pubmed">29370934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K., Liu Q., Shen D., Tai H., Fu H., Liu S., Wang Z., Shi J., Ding Q., Li X., et al. Genetic Analysis of TIA1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis. Neurobiol. Aging. 2018;67:201.e9&#x2013;201.e10. doi: 10.1016/j.neurobiolaging.2018.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.03.020</ArticleId><ArticleId IdType="pubmed">29699721</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Kim J.R., Van Bruggen R., Park J. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis. Mol. Cells. 2018;41:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes N., Eshleman N., Buchan J.R. RNA Metabolism in Neurodegenerative Diseases. Springer; Cham, Switzerland: 2018. Stress Granules and ALS: A Case of Causation or Correlation? pp. 173&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-89689-2_7</ArticleId><ArticleId IdType="pubmed">29916020</ArticleId></ArticleIdList></Reference><Reference><Citation>Baron D.M., Kaushansky L.J., Ward C.L., Sama R.R.K., Chian R.-J., Boggio K.J., Quaresma A.J., Nickerson J.A., Bosco D.A. Amyotrophic Lateral Sclerosis-Linked FUS/TLS Alters Stress Granule Assembly and Dynamics. Mol. Neurodegener. 2013;8:30. doi: 10.1186/1750-1326-8-30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-30</ArticleId><ArticleId IdType="pmc">PMC3766239</ArticleId><ArticleId IdType="pubmed">24090136</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T., Taylor J.P. Phase Separation by Low Complexity Domains Promotes Stress Granule Assembly and Drives Pathological Fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Dafinca R., Scaber J., Ababneh N., Lalic T., Weir G., Christian H., Vowles J., Douglas A.G.L., Fletcher-Jones A., Browne C., et al. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Demen. Stem Cells. 2016;34:2063&#x2013;2078. doi: 10.1002/stem.2388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2388</ArticleId><ArticleId IdType="pmc">PMC4979662</ArticleId><ArticleId IdType="pubmed">27097283</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Cook C., Gendron T.F., Jansen-West K., Del Rosso G., Daughrity L.M., Castanedes-Casey M., Kurti A., Stankowski J.N., Disney M.D., et al. Aberrant Deposition of Stress Granule-Resident Proteins Linked to C9orf72-Associated TDP-43 Proteinopathy. Mol. Neurodegener. 2019;14:1&#x2013;15. doi: 10.1186/s13024-019-0310-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0310-z</ArticleId><ArticleId IdType="pmc">PMC6377782</ArticleId><ArticleId IdType="pubmed">30767771</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S., Bogaert E., Kovacs D., Konijnenberg A., Timmerman E., Volkov A., Guharoy M., De Decker M., Jaspers T., Ryan V.H., et al. Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics. Mol. Cell. 2017;65:1044&#x2013;1055.e5. doi: 10.1016/j.molcel.2017.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.02.013</ArticleId><ArticleId IdType="pmc">PMC5364369</ArticleId><ArticleId IdType="pubmed">28306503</ArticleId></ArticleIdList></Reference><Reference><Citation>Marmor-Kollet H., Siany A., Kedersha N., Knafo N., Rivkin N., Danino Y.M., Moens T.G., Olender T., Sheban D., Cohen N., et al. Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis. Mol. Cell. 2020;80:876&#x2013;891. doi: 10.1016/j.molcel.2020.10.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.10.032</ArticleId><ArticleId IdType="pmc">PMC7816607</ArticleId><ArticleId IdType="pubmed">33217318</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P., Mathieu C., Kolaitis R.-M., Zhang P., Messing J., Yurtsever U., Yang Z., Wu J., Li Y., Pan Q., et al. G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules. Cell. 2020;181:325&#x2013;345.e28. doi: 10.1016/j.cell.2020.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.03.046</ArticleId><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S., Wheeler J.R., Walters R.W., Agrawal A., Barsic A., Parker R. ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. Cell. 2016;164:487&#x2013;498. doi: 10.1016/j.cell.2015.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.12.038</ArticleId><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Markmiller S., Soltanieh S., Server K.L., Mak R., Jin W., Fang M.Y., Luo E.-C., Krach F., Yang D., Sen A., et al. Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules. Cell. 2018;172:590&#x2013;604.e13. doi: 10.1016/j.cell.2017.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.12.032</ArticleId><ArticleId IdType="pmc">PMC5969999</ArticleId><ArticleId IdType="pubmed">29373831</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H., Ishiura H., Mitsui J., Date H., Takahashi Y., Matsukawa T., Tanaka M., Ishii A., Tamaoka A., Hokkoku K., et al. Molecular Epidemiological Study of Familial Amyotrophic Lateral Sclerosis in Japanese Population by Whole-Exome Sequencing and Identification of Novel HNRNPA1 Mutation. Neurobiol. Aging. 2018;61:255.e9&#x2013;255.e16. doi: 10.1016/j.neurobiolaging.2017.08.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.030</ArticleId><ArticleId IdType="pubmed">29033165</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn J.-Y., Dunham W.H., Hong S.J., Knight J.D., Bashkurov M., Chen G.I., Bagci H., Rathod B., MacLeod G., Eng S.W., et al. High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies. Mol. Cell. 2018;69:517&#x2013;532.e11. doi: 10.1016/j.molcel.2017.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2017.12.020</ArticleId><ArticleId IdType="pubmed">29395067</ArticleId></ArticleIdList></Reference><Reference><Citation>Figley M.D., Bieri G., Kolaitis R.-M., Taylor J.P., Gitler A.D. Profilin 1 Associates with Stress Granules and ALS-Linked Mutations Alter Stress Granule Dynamics. J. Neurosci. 2014;34:8083&#x2013;8097. doi: 10.1523/JNEUROSCI.0543-14.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0543-14.2014</ArticleId><ArticleId IdType="pmc">PMC4051967</ArticleId><ArticleId IdType="pubmed">24920614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Kuang L., Barnett K.R., Zhu B.Z., Shissler S.C., Korotkov K.V., Hayward L.J., Kasarskis E.J., Zhu H. ALS Mutant SOD1 Interacts with G3BP1 and Affects Stress Granule Dynamics. Acta Neuropathol. 2016;132:563&#x2013;576. doi: 10.1007/s00401-016-1601-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1601-x</ArticleId><ArticleId IdType="pmc">PMC5023729</ArticleId><ArticleId IdType="pubmed">27481264</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateju D., Franzmann T.M., Patel A., Kopach A., Boczek E.E., Maharana S., Lee H.O., Carra S., Hyman A.A., Alberti S. An Aberrant Phase Transition of Stress Granules Triggered by Misfolded Protein and Prevented by Chaperone Function. EMBO J. 2017;36:1669&#x2013;1687. doi: 10.15252/embj.201695957.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201695957</ArticleId><ArticleId IdType="pmc">PMC5470046</ArticleId><ArticleId IdType="pubmed">28377462</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Ros M., Deol H.K., Savard A., Guo H., Meiering E.M., Gibbings D. Wild-Type and Mutant SOD1 Localizes to RNA-Rich Structures in Cells and Mice but Does Not Bind RNA. J. Neurochem. 2021;156:524&#x2013;538. doi: 10.1111/jnc.15126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15126</ArticleId><ArticleId IdType="pubmed">32683701</ArticleId></ArticleIdList></Reference><Reference><Citation>Luisier R., Tyzack G.E., Hall C.E., Mitchell J.S., Devine H., Taha D.M., Malik B., Meyer I., Greensmith L., Newcombe J., et al. Intron Retention and Nuclear Loss of SFPQ Are Molecular Hallmarks of ALS. Nat. Commun. 2018;9:1&#x2013;15. doi: 10.1038/s41467-018-04373-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04373-8</ArticleId><ArticleId IdType="pmc">PMC5964114</ArticleId><ArticleId IdType="pubmed">29789581</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann D., Parlato R. C9orf72-Associated Neurodegeneration in ALS-FTD: Breaking New Ground in Ribosomal RNA and Nucleolar Dysfunction. Cell Tissue Res. 2018;373:351&#x2013;360. doi: 10.1007/s00441-018-2806-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-018-2806-1</ArticleId><ArticleId IdType="pubmed">29450726</ArticleId></ArticleIdList></Reference><Reference><Citation>Latonen L. Phase-to-Phase with Nucleoli&#x2014;Stress Responses, Protein Aggregation and Novel Roles of RNA. Front. Cell. Neurosci. 2019;13:151. doi: 10.3389/fncel.2019.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00151</ArticleId><ArticleId IdType="pmc">PMC6497782</ArticleId><ArticleId IdType="pubmed">31080406</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangan H., Gail&#xed;n M.&#xd3;., McStay B. Integrating the Genomic Architecture of Human Nucleolar Organizer Regions with the Biophysical Properties of Nucleoli. FEBS J. 2017;284:3977&#x2013;3985. doi: 10.1111/febs.14108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.14108</ArticleId><ArticleId IdType="pubmed">28500793</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hwang Y.J., Ryu H., Kowall N.W., Ryu H. Nucleolar Dysfunction in Huntington&#x2019;s Disease. Biochim. Biophys. Acta (BBA) Bioenerg. 2014;1842:785&#x2013;790. doi: 10.1016/j.bbadis.2013.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2013.09.017</ArticleId><ArticleId IdType="pmc">PMC3972370</ArticleId><ArticleId IdType="pubmed">24184605</ArticleId></ArticleIdList></Reference><Reference><Citation>Evsyukov V., Domanskyi A., Bierhoff H., Gispert S., Mustafa R., Schlaudraff F., Liss B., Parlato R. Genetic Mutations Linked to Parkinson&#x2019;s Disease Differentially Control Nucleolar Activity in Pre-symptomatic Mouse Models. Dis. Model. Mech. 2017;10:633&#x2013;643. doi: 10.1242/dmm.028092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.028092</ArticleId><ArticleId IdType="pmc">PMC5451170</ArticleId><ArticleId IdType="pubmed">28360124</ArticleId></ArticleIdList></Reference><Reference><Citation>Jesse S., Bayer H., Alupei M.C., Z&#xfc;gel M., Mulaw M., Tuorto F., Malmsheimer S., Singh K., Steinacker J., Schumann U., et al. Ribosomal Transcription is Regulated by PGC-1alpha and Disturbed in Huntington&#x2019;s Disease. Sci. Rep. 2017;7:1&#x2013;10. doi: 10.1038/s41598-017-09148-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09148-7</ArticleId><ArticleId IdType="pmc">PMC5561056</ArticleId><ArticleId IdType="pubmed">28819135</ArticleId></ArticleIdList></Reference><Reference><Citation>White M.R., Mitrea D.M., Zhang P., Stanley C.B., Cassidy D.E., Nourse A., Phillips A.H., Tolbert M., Taylor J.P., Kriwacki R.W. C9orf72 Poly(PR) Dipeptide Repeats Disturb Biomolecular Phase Separation and Disrupt Nucleolar Function. Mol. Cell. 2019;74:713&#x2013;728.e6. doi: 10.1016/j.molcel.2019.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.019</ArticleId><ArticleId IdType="pmc">PMC6525025</ArticleId><ArticleId IdType="pubmed">30981631</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Harada Y., Fujimoto M., Yagi T., Hayamizu Y., Nagaoka K., Kuroda M. Characterization of Membrane Penetration and Cytotoxicity of C9orf72-Encoding Arginine-Rich Dipeptides. Sci. Rep. 2018;8:1&#x2013;11. doi: 10.1038/s41598-018-31096-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31096-z</ArticleId><ArticleId IdType="pmc">PMC6109075</ArticleId><ArticleId IdType="pubmed">30143685</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. The Proline&#x2013;Arginine Repeat Protein Linked to C9-ALS/FTD Causes Neuronal Toxicity by Inhibiting the DEAD-Box RNA Helicase-Mediated Ribosome Biogenesis. Cell Death Dis. 2018;9:1&#x2013;16. doi: 10.1038/s41419-018-1028-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1028-5</ArticleId><ArticleId IdType="pmc">PMC6155127</ArticleId><ArticleId IdType="pubmed">30250194</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Z., Wang H., Xia Q., Li K., Li K., Jiang X., Xu G., Wang G., Ying Z. Nucleolar Stress and Impaired Stress Granule Formation Contribute to C9orf72 RAN Translation-Induced Cytotoxicity. Hum. Mol. Genet. 2015;24:2426&#x2013;2441. doi: 10.1093/hmg/ddv005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddv005</ArticleId><ArticleId IdType="pubmed">25575510</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X., Tan W., Westergard T., Krishnamurthy K., Markandaiah S.S., Shi Y., Lin S., Shneider N.A., Monaghan J., Pandey U.B., et al. Antisense Proline-Arginine RAN Dipeptides Linked to C9ORF72-ALS/FTD Form Toxic Nuclear Aggregates that Initiate In Vitro and In Vivo Neuronal Death. Neuron. 2014;84:1213&#x2013;1225. doi: 10.1016/j.neuron.2014.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Rothstein J.D. The Expanding Biology of the C9orf72 Nucleotide Repeat Expansion in Neurodegenerative Disease. Nat. Rev. Neurosci. 2016;17:383&#x2013;395. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A.J., Shaw P.G., Kim M.-S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., et al. C9orf72 Nucleotide Repeat Structures Initiate Molecular Cascades of Disease. Nat. Cell Biol. 2014;507:195&#x2013;200. doi: 10.1038/nature13124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13124</ArticleId><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., An Y., Chen Z.S., Koon A.C., Lau K.-F., Ngo J.C.K., Chan H.Y.E. A Peptidylic Inhibitor for Neutralizing (GGGGCC)-Associated Neurodegeneration in C9ALS-FTD. Mol. Ther. Nucleic Acids. 2019;16:172&#x2013;185. doi: 10.1016/j.omtn.2019.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.02.015</ArticleId><ArticleId IdType="pmc">PMC6424097</ArticleId><ArticleId IdType="pubmed">30889483</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Rourke J.G., Bogdanik L., Muhammad A., Gendron T.F., Kim K.J., Austin A., Cady J., Liu E.Y., Zarrow J., Grant S., et al. C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD. Neuron. 2015;88:892&#x2013;901. doi: 10.1016/j.neuron.2015.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2015.10.027</ArticleId><ArticleId IdType="pmc">PMC4672384</ArticleId><ArticleId IdType="pubmed">26637796</ArticleId></ArticleIdList></Reference><Reference><Citation>Trinkle-Mulcahy L., Sleeman J.E. The Cajal Body and the Nucleolus: &#x201c;In a Relationship&#x201d; or &#x201c;It&#x2019;s Complicated&#x201d;? RNA Biol. 2016;14:739&#x2013;751. doi: 10.1080/15476286.2016.1236169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1236169</ArticleId><ArticleId IdType="pmc">PMC5519233</ArticleId><ArticleId IdType="pubmed">27661468</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe1;dy B.E., Richard P., Bertrand E., Kiss T. Cell Cycle-Dependent Recruitment of Telomerase RNA and Cajal Bodies to Human Telomeres. Mol. Biol. Cell. 2006;17:944&#x2013;954. doi: 10.1091/mbc.e05-09-0904.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.e05-09-0904</ArticleId><ArticleId IdType="pmc">PMC1356602</ArticleId><ArticleId IdType="pubmed">16319170</ArticleId></ArticleIdList></Reference><Reference><Citation>Spector D.L., Lamond A.I. Nuclear Speckles. Cold Spring Harb. Perspect. Biol. 2010;3:a000646. doi: 10.1101/cshperspect.a000646.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000646</ArticleId><ArticleId IdType="pmc">PMC3039535</ArticleId><ArticleId IdType="pubmed">20926517</ArticleId></ArticleIdList></Reference><Reference><Citation>Galganski L., Urbanek M.O., Krzyzosiak W.J. Nuclear Speckles: Molecular Organization, Biological Function and Role in Disease. Nucleic Acids Res. 2017;45:10350&#x2013;10368. doi: 10.1093/nar/gkx759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx759</ArticleId><ArticleId IdType="pmc">PMC5737799</ArticleId><ArticleId IdType="pubmed">28977640</ArticleId></ArticleIdList></Reference><Reference><Citation>Jobbins A.M., Reichenbach L.F., Lucas C.M., Hudson A.J., Burley G.A., Eperon I.C. The Mechanisms of a Mammalian Splicing Enhancer. Nucleic Acids Res. 2018;46:2145&#x2013;2158. doi: 10.1093/nar/gky056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky056</ArticleId><ArticleId IdType="pmc">PMC5861446</ArticleId><ArticleId IdType="pubmed">29394380</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao E.S., Regev O. Splicing at the Phase-Separated Nuclear Speckle Interface: A Model. Nucleic Acids Res. 2021;49:636&#x2013;645. doi: 10.1093/nar/gkaa1209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1209</ArticleId><ArticleId IdType="pmc">PMC7826271</ArticleId><ArticleId IdType="pubmed">33337476</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha M. Transcription Boosting by Nuclear Speckles. Nat. Rev. Mol. Cell Biol. 2019;21:64&#x2013;65. doi: 10.1038/s41580-019-0203-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0203-6</ArticleId><ArticleId IdType="pubmed">31848471</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Wang L., Wang J., Chen S., Shi M., Cheng H. Intronless mRNAs Transit through Nuclear Speckles to Gain Export Competence. J. Cell Biol. 2018;217:3912&#x2013;3929. doi: 10.1083/jcb.201801184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201801184</ArticleId><ArticleId IdType="pmc">PMC6219727</ArticleId><ArticleId IdType="pubmed">30194269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Yagi T., Cammack A.J., Mahadevan J., Kuroda M., Harms M.B., Miller T.M., Urano F. Poly-Dipeptides Encoded by the C9ORF72 Repeats Block Global Protein Translation. Hum. Mol. Genet. 2016;25:1803&#x2013;1813. doi: 10.1093/hmg/ddw052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw052</ArticleId><ArticleId IdType="pmc">PMC4986334</ArticleId><ArticleId IdType="pubmed">26931465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N., Kovalik T., Lorenzini I., Spangler S., Lacoste A., Sponaugle K., Ferrante P., Argentinis E., Sattler R., Bowser R. Artificial Intelligence in Neurodegenerative Disease Research: Use of IBM Watson to Identify Additional RNA-Binding Proteins Altered in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2018;135:227&#x2013;247. doi: 10.1007/s00401-017-1785-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1785-8</ArticleId><ArticleId IdType="pmc">PMC5773659</ArticleId><ArticleId IdType="pubmed">29134320</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I.-F., Reddy N.M., Shen C.-K.J. Higher Order Arrangement of the Eukaryotic Nuclear Bodies. Proc. Natl. Acad. Sci. USA. 2002;99:13583&#x2013;13588. doi: 10.1073/pnas.212483099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.212483099</ArticleId><ArticleId IdType="pmc">PMC129717</ArticleId><ArticleId IdType="pubmed">12361981</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Li L., Lin W.-L., Dickson D.W., Petrucelli L., Zhang T., Wang X. The ALS Disease-Associated Mutant TDP-43 Impairs Mitochondrial Dynamics and Function in Motor Neurons. Hum. Mol. Genet. 2013;22:4706&#x2013;4719. doi: 10.1093/hmg/ddt319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt319</ArticleId><ArticleId IdType="pmc">PMC3820133</ArticleId><ArticleId IdType="pubmed">23827948</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling J.P., Pletnikova O., Troncoso J.C., Wong P.C. TDP-43 Repression of Nonconserved Cryptic Exons Is Compromised in ALS-FTD. Sciences. 2015;349:650&#x2013;655. doi: 10.1126/science.aab0983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aab0983</ArticleId><ArticleId IdType="pmc">PMC4825810</ArticleId><ArticleId IdType="pubmed">26250685</ArticleId></ArticleIdList></Reference><Reference><Citation>Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.-C., Sun E., Wancewicz E., Mazur C., et al. Long Pre-mRNA Depletion and RNA Missplicing Contribute to Neuronal Vulnerability from Loss of TDP-43. Nat. Neurosci. 2011;14:459&#x2013;468. doi: 10.1038/nn.2779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2779</ArticleId><ArticleId IdType="pmc">PMC3094729</ArticleId><ArticleId IdType="pubmed">21358643</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H., Shibagaki Y., Hattori S., Matsuoka M. C9-ALS/FTD-Linked Proline&#x2013;Arginine Dipeptide Repeat Protein Associates with Paraspeckle Components and Increases Paraspeckle Formation. Cell Death Dis. 2019;10:1&#x2013;16. doi: 10.1038/s41419-019-1983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="pubmed">31582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Fox A.H., Nakagawa S., Hirose T., Bond C.S. Paraspeckles: Where Long Noncoding RNA Meets Phase Separation. Trends Biochem. Sci. 2018;43:124&#x2013;135. doi: 10.1016/j.tibs.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2017.12.001</ArticleId><ArticleId IdType="pubmed">29289458</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisani G., Baron B. Nuclear Paraspeckles Function in Mediating Gene Regulatory and Apoptotic Pathways. Non-Coding RNA Res. 2019;4:128&#x2013;134. doi: 10.1016/j.ncrna.2019.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2019.11.002</ArticleId><ArticleId IdType="pmc">PMC7012776</ArticleId><ArticleId IdType="pubmed">32072080</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa S., Yamazaki T., Hirose T. Molecular Dissection of Nuclear Paraspeckles: Towards Understanding the Emerging World of the RNP Milieu. Open Biol. 2018;8:8. doi: 10.1098/rsob.180150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.180150</ArticleId><ArticleId IdType="pmc">PMC6223218</ArticleId><ArticleId IdType="pubmed">30355755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesi A., Staahl B.T., Jovi&#x10d;i&#x107; A., Couthouis J., Fasolino M., Raphael A.R., Yamazaki T., Elias L., Polak M., Kelly C., et al. Exome Sequencing to Identify de Novo Mutations in Sporadic ALS Trios. Nat. Neurosci. 2013;16:851&#x2013;855. doi: 10.1038/nn.3412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3412</ArticleId><ArticleId IdType="pmc">PMC3709464</ArticleId><ArticleId IdType="pubmed">23708140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic Mutations in RNA-Binding Proteins and Their Roles in ALS. Qual. Life Res. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas-Jinu S., Gordon P.M., Fielding T., Taylor R., Smith B.N., Snowden V., Blanc E., Vance C., Topp S., Wong C.-H., et al. Non-nuclear Pool of Splicing Factor SFPQ Regulates Axonal Transcripts Required for Normal Motor Development. Neuron. 2017;94:322&#x2013;336.e5. doi: 10.1016/j.neuron.2017.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.026</ArticleId><ArticleId IdType="pmc">PMC5405110</ArticleId><ArticleId IdType="pubmed">28392072</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y., Nakagawa S., Hirose T., Okano H.J., Takao M., Shibata S., Suyama S., Kuwako K.-I., Imai T., Murayama S., et al. The Long Non-coding RNA Nuclear-Enriched Abundant Transcript 1_2 Induces Paraspeckle Formation in the Motor Neuron during the Early Phase of Amyotrophic Lateral Sclerosis. Mol. Brain. 2013;6:31. doi: 10.1186/1756-6606-6-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai P., Bandopadhyay R. Pathophysiological Implications of RNP Granules in Frontotemporal Dementia and ALS. Neurochem. Int. 2020;140:104819. doi: 10.1016/j.neuint.2020.104819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2020.104819</ArticleId><ArticleId IdType="pubmed">32763254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Duan Y., Duan G., Wang Q., Zhang K., Deng X., Qian B., Gu J., Ma Z., Zhang S., et al. Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid Phase Separation. Mol. Cell. 2020;79:443&#x2013;458.e7. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamazaki T., Nakagawa S., Hirose T. Architectural RNAs for Membraneless Nuclear Body Formation. Cold Spring Harb. Symp. Quant. Biol. 2019;84:227&#x2013;237. doi: 10.1101/sqb.2019.84.039404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2019.84.039404</ArticleId><ArticleId IdType="pubmed">32019862</ArticleId></ArticleIdList></Reference><Reference><Citation>An H., Skelt L., Notaro A., Highley J.R., Fox A.H., La Bella V., Buchman V.L., Shelkovnikova T.A. ALS-Linked FUS Mutations Confer Loss and Gain of Function in the Nucleus by Promoting Excessive Formation of Dysfunctional Paraspeckles. Acta Neuropathol. Commun. 2019;7:1&#x2013;14. doi: 10.1186/s40478-019-0658-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0658-x</ArticleId><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x10c;esnik A.B., Darovic S., Mihevc S.P., &#x160;talekar M., Malnar M., Motaln H., Lee Y.-B., Mazej J., Pohleven J., Grosch M., et al. Nuclear RNA Foci from C9ORF72 Expansion Mutation Form Paraspeckle-like Bodies. J. Cell Sci. 2019;132:jcs224303. doi: 10.1242/jcs.224303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.224303</ArticleId><ArticleId IdType="pubmed">30745340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bampton A., Gittings L.M., Fratta P., Lashley T., Gatt A. The Role of hnRNPs in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2020;140:599&#x2013;623. doi: 10.1007/s00401-020-02203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02203-0</ArticleId><ArticleId IdType="pmc">PMC7547044</ArticleId><ArticleId IdType="pubmed">32748079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gittings L.M., Foti S.C., Benson B.C., Gami-Patel P., Isaacs A.M., Lashley T. Heterogeneous Nuclear Ribonucleoproteins R and Q Accumulate in Pathological Inclusions in FTLD-FUS. Acta Neuropathol. Commun. 2019;7:1&#x2013;13. doi: 10.1186/s40478-019-0673-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0673-y</ArticleId><ArticleId IdType="pmc">PMC6371513</ArticleId><ArticleId IdType="pubmed">30755280</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Lu L., Sharma A., Yamazaki T., Tang T., Shneider N.A., Manley J.L. The C9ORF72 GGGGCC Expansion Forms RNA G-Quadruplex Inclusions and Sequesters hnRNP H to Disrupt Splicing in ALS Brains. eLife. 2016;5:e17820. doi: 10.7554/eLife.17820.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.17820</ArticleId><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshaies J.-E., Shkreta L., Moszczynski A.J., Sidib&#xe9; H., Semmler S., Fouillen A., Bennett E.R., Bekenstein U., Destroismaisons L., Toutant J., et al. TDP-43 Regulates the Alternative Splicing of hnRNP A1 to Yield an Aggregation-Prone Variant in Amyotrophic Lateral Sclerosis. Brain. 2018;141:1320&#x2013;1333. doi: 10.1093/brain/awy062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy062</ArticleId><ArticleId IdType="pmc">PMC5917749</ArticleId><ArticleId IdType="pubmed">29562314</ArticleId></ArticleIdList></Reference><Reference><Citation>Frottin F., Schueder F., Tiwary S., Gupta R., K&#xf6;rner R., Schlichthaerle T., Cox J., Jungmann R., Hartl F.U., Hipp M.S. The Nucleolus Functions as a Phase-Separated Protein Quality Control Compartment. Science. 2019;365:342&#x2013;347. doi: 10.1126/science.aaw9157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaw9157</ArticleId><ArticleId IdType="pubmed">31296649</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee K.-H., Woo K.-C., Kim D.-Y., Kim T.-D., Shin J., Park S.M., Jang S.K., Kim K.-T. Rhythmic Interaction between Period1 mRNA and hnRNP Q Leads to Circadian Time-Dependent Translation. Mol. Cell. Biol. 2011;32:717&#x2013;728. doi: 10.1128/MCB.06177-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.06177-11</ArticleId><ArticleId IdType="pmc">PMC3266596</ArticleId><ArticleId IdType="pubmed">22124155</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C., Allada R. Emerging Roles for Post-transcriptional Regulation in Circadian Clocks. Nat. Neurosci. 2013;16:1544&#x2013;1550. doi: 10.1038/nn.3543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3543</ArticleId><ArticleId IdType="pubmed">24165681</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton J.G., Mayer S.A., Tempst P., Nadal-Ginard B. Characterization and Molecular Cloning of Polypyrimidine Tract-Binding Protein: A Component of a Complex Necessary for Pre-mRNA Splicing. Genes Dev. 1991;5:1237&#x2013;1251. doi: 10.1101/gad.5.7.1237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.5.7.1237</ArticleId><ArticleId IdType="pubmed">1906036</ArticleId></ArticleIdList></Reference><Reference><Citation>Galb&#xe1;n S., Kuwano Y., Pullmann R., Martindale J.L., Kim H.H., Lal A., Abdelmohsen K., Yang X., Dang Y., Liu J.O., et al. RNA-Binding Proteins HuR and PTB Promote the Translation of Hypoxia-Inducible Factor 1&#x3b1;. Mol. Cell. Biol. 2007;28:93&#x2013;107. doi: 10.1128/MCB.00973-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00973-07</ArticleId><ArticleId IdType="pmc">PMC2223304</ArticleId><ArticleId IdType="pubmed">17967866</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo K.-C., Kim T.-D., Lee K.-Y., Kim D.-Y., Kim W., Kim K.-T. Mouse Period 2 mRNA cIrcadian Oscillation Is Modulated by PTB&#x2013;Mediated Rhythmic mRNA Degradation. Nucleic Acids Res. 2008;37:26&#x2013;37. doi: 10.1093/nar/gkn893.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn893</ArticleId><ArticleId IdType="pmc">PMC2615616</ArticleId><ArticleId IdType="pubmed">19010962</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., Shorter J., DeJesus-Hernandez M., Erion R., Oristano R., Liu A.X., Ramos D., Jethava N., Hosangadi D., et al. A Yeast Functional Screen Predicts New Candidate ALS Disease Genes. Proc. Natl. Acad. Sci. USA. 2011;108:20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Raphael A.R., Daneshjou R., Gitler A.D. Targeted Exon Capture and Sequencing in Sporadic Amyotrophic Lateral Sclerosis. PLoS Genet. 2014;10:e1004704. doi: 10.1371/journal.pgen.1004704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004704</ArticleId><ArticleId IdType="pmc">PMC4191946</ArticleId><ArticleId IdType="pubmed">25299611</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A., Eitan C., Liou L., Libby R.T., Rivkin N., Magen I., Reichenstein I., Oppenheim H., Eilam R., Silvestroni A., et al. Dysregulated mi RNA Biogenesis Downstream of Cellular Stress and ALS-Causing Mutations: A New Mechanism for ALS. EMBO J. 2015;34:2633&#x2013;2651. doi: 10.15252/embj.201490493.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pmc">PMC4641530</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z., Patten S.A. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Front. Genet. 2019;9:712. doi: 10.3389/fgene.2018.00712.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2018.00712</ArticleId><ArticleId IdType="pmc">PMC6349704</ArticleId><ArticleId IdType="pubmed">30723494</ArticleId></ArticleIdList></Reference><Reference><Citation>Aakalu G., Smith W., Nguyen N., Jiang C., Schuman E.M. Dynamic Visualization of Local Protein Synthesis in Hippocampal Neurons. Neuron. 2001;30:489&#x2013;502. doi: 10.1016/S0896-6273(01)00295-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(01)00295-1</ArticleId><ArticleId IdType="pubmed">11395009</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung Y., Seo J.-Y., Ryu H.G., Kim D.-Y., Lee K.-H., Kim K.-T. BDNF-Induced Local Translation of GluA1 is Regulated by HNRNP A2/B1. Sci. Adv. 2020;6:eabd2163. doi: 10.1126/sciadv.abd2163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd2163</ArticleId><ArticleId IdType="pmc">PMC7679154</ArticleId><ArticleId IdType="pubmed">33219033</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo G., Holste D., Kreiman G., Burge C.B. Variation in Alternative Splicing across Human Tissues. Genome Biol. 2004;5:R74. doi: 10.1186/gb-2004-5-10-r74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2004-5-10-r74</ArticleId><ArticleId IdType="pmc">PMC545594</ArticleId><ArticleId IdType="pubmed">15461793</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>